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Abstract
OBJECTIVES: We aimed to investigate the association of patient characteristics and allogeneic blood transfusion products in development
of post-cardiac surgery nosocomial infections.
METHODS: This retrospective study was conducted in 7888 patients undergoing cardiac surgery with median sternotomy and cardiopul-
monary bypass. Multivariable logistic regression analysis was used for independent effect of variables on infections.
RESULTS: A total of 970 (12.3%) patients developed one or several types of postoperative infections. Urinary (n = 351, 4.4%) and pulmonary
tract infections (n = 478, 6.1%) occurred more frequently than sternal wound infections (superﬁcial: n = 102, 1.3%, deep: n = 72, 0.9%) and
donor site infections (n = 61, 0.8%). Interventions, including valve replacement (P = 0.002) and coronary artery bypass grafting combined
with valve replacement (P = 0.012), were associated with increased risk of several types of postoperative infections. Patients’ proﬁles
changed substantially over the years; morbid obesity (P = 0.019), smoking (P = 0.001) and diabetes mellitus (P = 0.001) occur more fre-
quently nowadays. Furthermore, surgical site infections showed to be related to morbid obesity (P < 0.001) and higher risk stratiﬁcation
(P = 0.031). Smoking (P < 0.001) and chronic obstructive pulmonary disease (P < 0.001) were related to pulmonary tract infections. In add-
ition, diabetic patients developed more sepsis (P = 0.003) and advanced age was associated with development of urinary tract infections
(P < 0.001). Even after correcting for other factors, blood transfusion was associated with all types of postoperative infection (P < 0.001).
This effect remained present in both leucocyte-depleted and non-leucocyte-depleted transfusion.
CONCLUSIONS: Our data showed that post-cardiac surgery infections occur more frequently in patients with predetermined risk factors.
The amount of blood transfusions was integrally related to every type of postoperative infection.
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INTRODUCTION
Infections following cardiac surgery remain a major burden for
patients’ morbidity, causing prolonged hospital stay, and thereby
higher health-care costs [1, 2]. Reported incidence rates of noso-
comial infections vary from 5 to 21% in patients undergoing cardiac
surgery using cardiopulmonary bypass (CPB) [3]. In general, these
infections are conjectured to be related to contamination and
tissue traumatization during coronary artery bypass grafting (CABG)
surgery, whereas host resistance compromised by the severity of
the underlying disease appears to be more important during
cardiac valve surgery [4]. Moreover, allogeneic blood transfusion,
although considered safe, has shown to play a pivotal role in the
development of postoperative infections mediated through im-
munosuppression [5–7]. Several studies report blood transfusion
to have negative effects on patients’ health, but contradictions
about this statement remain present [8, 9]. Furthermore, previous
studies show that patient-related factors (age, gender, diabetes
mellitus and reduced left ventricle ejection fraction) and duration
of CPB are associated with an increase in development of infec-
tions after cardiac surgical interventions [3, 10].
Generally, the statistical power of many studies is adequate for
investigation of one or two infection types, while the sample size
may be not be sufﬁcient to investigate multiple types of infection.
Moreover, the focus is often on a particular type of infection, and
not all possible related factors are included. On the other hand,
the cardiac surgical patient population has changed substantially
over the past years. Patients undergoing CABG surgery nowadays
are older, more likely to be of female gender and of higher risk for
multiple postoperative complications compared with the popula-
tion a decade ago [11]. This change in patient proﬁles implies that
risk factors determined in previous studies are not transferable to
the current clinical practice.
The aim of this study was to determine the incidence of
postoperative nosocomial infections and secondly, to investi-
gate the contribution of blood transfusion (leucocyte-depleted
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or non-leucocyte-depleted packed red blood cells) in the devel-
opment of postoperative cardiac surgery infections during a
10-year time span.
MATERIALS ANDMETHODS
Patient population
This retrospective study included all adult patients who underwent
median sternotomy during a cardiac surgical intervention using
CPB between the years 1997 and 2006. Institutional approval was
granted based on a retrospective quality analysis of our patient
surgery database. Immediately after surgery, patients were admit-
ted to the cardiac intensive care unit. Urine catheters were
removed on the second day postoperatively. Exclusion criteria
were death in the operating room or within 30 days postopera-
tively, off-pump procedure and heart transplant. As a conse-
quence of CABG (with or without valve surgery), patients can
potentially develop a donor site infection (DSI). Data of these
patients were taken into analysis separately to determine the inci-
dence and risk factors associated.
Study design and data collection
The database of the Department of Cardiothoracic Surgery was
analysed to speciﬁcally obtain patient data for postoperative noso-
comial infections. After data collection, data cleaning and applying
exclusion criteria, 7888 patients remained for analysis.
Patients’ characteristics and information on the use of blood
transfusion products were matched with patient data, surgery data
and postoperative data. Infectious complications occurring after
surgery were registered and adopted as a postoperative nosoco-
mial infection. In this study, a total of 34 intraoperative variables
were taken into account, including patient-related data, surgery-
related factors, European system for cardiac operative risk evalu-
ation (EuroSCORE) and perioperative factors (Table 1) [12].
In the year 2002, a national transition to leucocyte-depleted
blood has taken place. To investigate whether this causes a change
in the role of blood transfusion and postoperative infections, the
entire patient population was split into a section before and after
2002.
Deﬁnitions
Wound infections were deﬁned according to the 1992 modiﬁed
deﬁnitions for wound infection of the Centres for Disease Control
and Prevention [13]. Blood stream and urinary tract infections
were diagnosed by at least one positive culture. Diagnosis of pul-
monary tract infection was conducted by detecting increased
body temperature (>37.5°C), pulmonary acoustics and a positive
sputum culture detection.
Statistical analysis
Statistical analysis was performed using Statistical Package for the
Social Sciences (SPSS Inc., Chicago, IL, USA). Numeric variables
were expressed as mean ± standard deviation or as median (inter-
quartile range), depending on the data distribution assessed by
the Kolmogorov–Smirnov test and visualization with histograms. A
P-value of <0.05 was considered signiﬁcant.
Means from continuous variables were compared using stu-
dent’s t-test for independent samples. To identify the relation
between each single risk factor and postoperative infections, uni-
variate analysis was performed for every type of infection, which
are superﬁcial sternal wound infection (SSWI), deep sternal
wound infection (DSWI), DSI, sepsis, urinary tract infection and
pulmonary tract infection. For the comparison of dichotomous
variables, the χ2 test was used. The Fisher’s exact test was con-
ducted when more than 20.0% of cells have an expected fre-
quency <5.
As univariate analysis does not adjust for possible confounding of
risk factors with each other, all variables were included in a multi-
variable logistic regression model using both stepwise backward
and forward selection of variables (Wald method). Non-normally
distributed continuous variables were log transformed before
adding into multivariate analysis.
To assess the impact of different numbers of blood transfusions,
the incidence rates of postoperative infection were analysed for
3–4, 5–6, 7–8, 9–10 and >10 transfusions compared with 1 or 2
transfusions.
Regarding the differences in risk of postoperative infections
either before or after leucocyte depletion, odds ratios (ORs) were
compared between two groups of patients. Since national transi-
tion to leucocyte-depleted red packed blood cells in 2002 was not
thoroughly executed within a speciﬁed time span, patients oper-
ated on in that year were not included in this part of the analysis
to minimize bias.
RESULTS
Patients
Of the 7888 patients, 30% (n = 2374) were female. The patient
population was divided into two groups (Table 2): patients with
Table 1: Preoperative, postoperative and perioperative
variables
Patient-related Gender, age, NYHA classification, morbid obesity,
diabetes mellitus, peripheral vascular disease,
hypertension, pulmonary hypertension, active
endocarditis, smoking, hypercholesterolaemia,
renal dysfunction, COPD, log EuroSCORE, LVEF,
previous MI, cerebrovascular diseasea,
immunosuppressive treatment, antibiotics,
inotropes, aspirin, β-blockers, nitrates,
antiaggregant therapy, steroids, digitalis.
Surgery-related Type of surgery, reoperation, CPB time, aortic
cross-clamping time, IABP, antiarrhythmics,
antifibrinolytics.
Perioperative Total amount of packed red blood cell transfusions.
COPD: chronic obstructive pulmonary disease; CPB: cardiopulmonary
bypass; EuroSCORE: European system for cardiac operative risk
evaluation; IABP: intra-aortic balloon pump; LVEF: left ventricle ejection
fraction; MI: myocardial infarct; NYHA: New York Heart Association.
aCerebrovascular disease includes cerebral vascular accident, transient
ischaemic attack, reversible ischaemic neurological deficit,
subarachnoidal bleeding and epilepsy.
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postoperative infections (n = 970) and patients without post-
operative infections (n = 6918). In the postoperative infection
cohort, no methicillin-resistant Staphylococcus aureus-induced
infection was observed. A total of 658 (8.7%) were admitted for
reoperative surgery. Surgical interventions included isolated CABG
(n = 5364, 68.0%), CABG combined with valve surgery (n = 800,
10.1%), valve surgery alone (n = 1222, 25.6%) and others such as
intercardial or intervascular corrective surgery (n = 502, 6.4%). A
rate of 78.1% patients underwent CABG or CABG combined with
valve surgery. This part of the patient population was used separ-
ately to further investigate DSIs.
A total of 5.6% (n = 430) of all patients was supported with an
intra-aortic balloon pump (IABP) perioperatively. A majority of
patients (n = 6781, 86%) received one or more homologous blood
products.
Patients’ proﬁle change over the years. Comparing patients ad-
mitted for surgery before and after 2002 (n = 3114 and n = 4036,
respectively), an increase was observed in the occurrence of
morbid obesity, diabetes mellitus and smoking after 2002. The
proportion of female patients did not change (Table 3).
Incidence of infection
In total, 970 (12.3%) patients developed one or more infections,
which lies within the reported range of 1.5–20%. An incidence pro-
portion of 478 (6.1%) patients developed airway infection, 351
(4.4%) urinary tract infection and 157 (3%) one or several surgical
site infections (SSI), including SSWI (n = 102, 1.3%), DSWI (n = 72,
0.9%) and DSI (n = 61, 0.8%). One hundred and forty (1.8%)
patients developed sepsis and 54 (0.7%) developed an unspeci-
ﬁed type of postoperative infection. The total number of diag-
nosed postoperative infections in 970 patients was 1258. In total,
698 (8.8%) patients had only one type of postoperative infection,
while 272 patients (3.4%) developed two or more separate types
of infections. In Fig. 1, an overview is shown of each infection
type and its contribution to the total number of postoperative
infections.
Mortality
The mortality rate in the infected group was 2.7%, which is signiﬁ-
cantly higher than the mortality incidence proportion of 0.7% in
the non-infected group (P < 0.001).
Table 3: Changes in patient population before and after
transition to leucocyte-depleted blood transfusion
Before 2002
(n = 4036)
After 2002
(n = 3114)
P-value
Female gender 1217 (30.2%) 936 (30.1%) 0.930
Morbid obesity 651 (16.1%) 568 (18.2%) 0.019
Diabetes mellitus 589 (14.6%) 545 (17.5%) 0.001
Smoking 952 (23.6%) 838 (26.9%) 0.001
Log EuroSCOREa 1.0 (1.2) 1.1 (1.3) <0.001
EuroSCORE: European System for Cardiac Operative Risk Evaluation.
aLog EuroSCORE is depicted as median (interquartile range).
Table 2: Univariate analysis of categorical variables
Infection group
(n = 970)
χ2 test
(P-value)
Gender
Female 334 (34.4%) 0.002
Male 636 (65.6%)
Smoking 230 (23.7%) 0.431
Diabetes mellitus 168 (17.3%) 0.213
Morbid obesity 186 (19.2%) 0.091
Peripheral vascular disease 64 (6.6%) 0.499
Hypertension 379 (39.1%) 0.697
Pulmonary hypertension 10 (1.0%) 0.071
Hypercholesterolaemia 349 (36.0%) 0.001
Chronic renal failure 65 (6.7%) 0.008
Active infected endocarditis 2 (0.2%) 1.00
COPD 116 (12.0%) <0.001
Preoperative medication
Immunosuppressive
treatment
5 (0.5%) 0.170
Digitalis 46 (4.7%) <0.001
β-Blockers 472 (48.7%) <0.001
ACE inhibitors 246 (25.4%) 0.306
Nitrates-PO 372 (38.4%) <0.001
Nitrates-IV 34 (3.5%) 0.214
Platelet aggregation
inhibitors
86 (8.9%) 0.020
Anticoagulation 70 (7.2%) 0.246
Inotropes 7 (0.7%) 0.087
Heparin 23 (2.4%) 0.186
Aspirin 343 (35.4%) 0.002
NSAID 15 (1.5%) 0.255
Corticosteroids 27 (2.8%) 0.035
Antibiotics 16 (1.6%) 0.809
Antacid 39 (4.0%) 0.453
Cerebrovascular diseasea 88 (9.1%) 0.001
NYHA-classification dyspnoea
I 32 (3.3%) 0.012
II 130 (13.4%)
III 204 (21%)
IV 38 (3.9%)
Myocardial infarct 290 (29.9%) 0.037
LVEF (%)
>50% 843 (9%) 0.276
30–50% 104 (10.7%)
<30% 23 (2.4%)
Reoperation 112 (11.5%) <0.001
Intra-aortic balloon pump 121 (12.5%) <0.001
Surgery
CABG 540 (55.7%) <0.001
CABG + valve replacement 162 (16.7%)
Valve replacement 190 (19.6%)
Other 78 (8.0%)
Medication at OR
Antifibrinolytics 548 (56.5%) <0.001
Inotropes 206 (21.2%) <0.001
Antiarrhythmics 8 (0.8%) 0.002
CABG: coronary artery bypass grafting; COPD: chronic obstructive
pulmonary disease; LVEF: left ventricle ejection fraction; NSAID:
non-steroidal anti-inflammatory drugs; NYHA: New York Heart
Association; OR: operating room; ACE: angiotensin-converting enzyme.
aCerebrovascular disease includes cerebral vascular accident, transient
ischaemic attack, reversible ischaemic neurological deficit,
subarachnoidal bleeding and epilepsy.
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Univariate analysis
Univariate analysis showed that patients with postoperative
infections are signiﬁcantly older (P < 0.001), and more likely to
be female (P = 0.002). These group of patients also had more
frequently dyspnoea (classiﬁcation III or IV) (P = 0.012), chronic
obstructive pulmonary disease (COPD) (P < 0.001), renal dys-
function (P = 0.008) and cerebrovascular disease (P = 0.001).
Furthermore, these patients received more digitalis (P < 0.001)
and corticosteroids preoperatively (P = 0.035), and received
more blood transfusion products (P < 0.001). CBP time was
signiﬁcantly longer between patients who did and patients
who did not develop any postoperative infection (P < 0.001)
(Tables 2 and 4).
In Fig. 2, an overview is shown of the increase in infection inci-
dence with increase in the number of transfusions (all groups
compared with the group 1–2 transfusions). When patients
received 5 or 6 transfusions, the incidence rate was signiﬁcantly
higher compared with that in patients who received 1 or 2 transfu-
sions. The infection incidence increased even further with a
higher number of transfusions given, and even doubled at more
than 10 transfusions.
Multivariate regression analysis
Outcomes of the forward (Wald statistic P < 0.05 for inclusion) and
backward (Wald statistic P < 0.10 for exclusion) multivariable logis-
tic regression analysis were mainly overlapping. Backward analysis
selected two more variables than forward analysis, which were
previous myocardial infarction and morbid obesity. The same
analysis was performed for all speciﬁed infection types, shown in
Table 5. The ﬁnal model (infections in general) derived from the
entire sample in forward multivariable logistic regression was
composed of the following variables: type of surgery: valve re-
placement and valve replacement combined with CABG (respect-
ively: OR = 1.355, P = 0.002 and OR = 1.343, P = 0.012); perfusion
time (OR = 1.375, P = 0.001); EuroSCORE (OR = 1.114, P = 0.042);
COPD (OR = 1.602, P < 0.001); preoperative administration of digi-
talis (OR = 1.487, P = 0.027); interoperative administration of antiﬁ-
brinolytics (OR = 1.315, P < 0.001) and inotropes (OR = 1.459,
P < 0.001); use of an IABP (OR = 2.250, P < 0.001); age (OR = 1.011,
P = 0.010); body mass index (OR = 1.794, P = 0.001); cerebrovascu-
lar disease (OR = 1.363, P = 0.016) and number of blood transfu-
sions (OR = 1.326, P < 0.001) (Table 6).
When considering the role of blood transfusion in the develop-
ment of postoperative infection before and after 2002, the OR for
the amount of blood transfusion units was slightly lowered after
2002. Analysis revealed ORs of 1.59 (infection in general, forward
selection of variables, 95% conﬁdence interval (CI) 1.32–1.93,
P < 0.001) and 1.31 (95% CI 1.18–1.46, P < 0.001) for the cohort
dating from 1997 to 2001 and 2003 to 2009, respectively.
DISCUSSION
Our study showed that at least one postoperative infection oc-
curred in 12.3% of patients, which is in line with a previously
reported range of 5–21% [3]. Furthermore, post-cardiac surgery
infections occur more frequently in patients with predetermined
Table 4: Univariate analysis of numerical variables
Infection group
(n = 970)
P-value, independent
samples t-test/Mann–
Whitney U-testMean ± SD/
Median (IQR)
Age (years at the date of
surgery)
66.63 ± 10.24 <0.001
BMI (kg/m2) 26.81 (5.35) 0.859
Logistic EuroSCORE (%) 3.70 (4.51) <0.001
CPB time (min) 4.59 (71.25) <0.001
Aorta-occlusion time
(min)
4.10 (50) <0.001
Erythrocyte blood
transfusion units
administrated
perioperatively
4.00 (5.0) <0.001
BMI: body mass index; CPB: cardiopulmonary bypass; EuroSCORE:
European System for Cardiac Operative Risk Evaluation; SD: standard
deviation; IQR: interquartile range.
Figure 1: Frequency of different types of postoperative infections within total
number of infections. Figure 2: Infection rate compared with the number of allogeneic blood pro-
ducts transfused compared with 1–2 blood products.
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risk factors. Particularly, blood transfusion appeared to be a pre-
dominant factor in development of all types of postoperative
infections. Another major ﬁnding was the change in patient risk
proﬁles over time, and thus a change in risk for postoperative
infections. A previous study by Ferguson et al. underlines the im-
portance of monitoring patients’ proﬁles over time in order to in-
vestigate the causes of postoperative complications, including
infectious diseases [11].
In contrast to what one may expect, sternal wound infections
were present in a much lesser extent. Two percent of all patients
developed one or more SSI (mediastinitis and donor site), which
was fairly low compared with the previously reported rates of 1.1–
13.5% [6, 14–16]. This difference may be explained by the extent in
sample size and/or focus of a single type of surgery in many
studies. In addition, patient-related factors could also vary
between the cohorts, as we found that patient-related factors such
as smoking, obesity and diabetes mellitus were associated with
surgical wound infections and sepsis. Other studies found the
same association for the factors obesity and diabetes mellitus with
SSI [6, 14]. Additionally, a recent study by Lee et al. describes the
relationship between COPD and SSI, which our results did not
reﬂect. Further, respiratory and urinary tract infections occurred
most frequently with a 6.1% rate of pulmonary tract infections,
which again lies within the documented range of 1.2–6.5% [10,
17]. Considering another risk factor, CPB duration was positively
related to development of postoperative infection, as mentioned
in several other studies [3, 18, 19]. Our results reﬂect this
association for DSIs, urinary tract infection and pulmonary tract
infection. Also, our results showed an association between female
gender and advanced age and urinary and pulmonary tract infec-
tions, which is in part conﬁrmed in a previous study conducted by
Riera et al. [10]. Furthermore, our results showed a relationship
between patient-related risk factors COPD and smoking and pul-
monary tract infections, which is contradictive to Riera’s ﬁndings.
This may be explained by differences in inclusion and exclusion
criteria compared with our study. Nonetheless, one of the risk
factors found to be related to urinary tract infections was female
gender, which conﬁrms the ﬁndings of Kollef et al. [18].
We observed a change in patient-related risk factors as time
progressed; patients more often become morbidly obese, diabetic
and smoker and have a higher risk stratiﬁcation score. As has been
shown in our results and other studies, an increase in one or
several of these risk factors causes an increase in the chances of
postoperative infection occurrence.
On the other hand, blood transfusion was associated with a sig-
niﬁcantly increased risk in all infection types. Most importantly,
this dose-dependent effect persisted when all other patient- and
surgery-related risk factors and leucocyte depletion were included
in analysis. The OR was slightly lowered after the implementation
of leucocyte depletion; however, its impact remained present and
statistically signiﬁcant. New auto-transfusion techniques and blood-
sparing developments, which play a pivotal role in cardiac surgery to
this day, help the demand for transfusion products to slightly reduce
over the years. However, blood transfusion remained independently
associated with development of all types of postoperative infections.
The increase in susceptibility for postoperative infection in
patients receiving red blood cell transfusions has been described
previously in several studies [3, 6, 15, 17, 20]. One of these studies
Table 6: Overview of multivariable logistic regression
analysis by forward selection of variables for infection in
general
Any type of infection Odds
ratio
95% CI P-value
Forward selection
Type of surgery*
CABG + valve replacement* 1.343 1.066–1.692 0.012
Valve replacement* 1.355 1.114–1.649 0.002
Other 1.060 0.790–1.422 0.698
COPD 1.602 1.279–2.007 0.000
Medication digitalis
preoperatively
1.487 1.046–2.115 0.027
Antifibrinolytics 1.315 1.141–1.515 <0.001
Inotropes 1.459 1.193–1.783 <0.001
Intra-aortic balloon pump 2.250 1.755–2.883 <0.001
Age 1.011 1.003–1.020 0.010
CPB time (min) 1.375 1.146–1.649 0.001
Log EuroSCORE 1.114 1.004–1.237 0.042
Number of transfusion products 1.326 1.200–1.466 <0.001
Body mass index 1.794 1.271–2.532 0.001
Cerebrovascular diseasea 1.363 1.059–1.753 0.016
CABG: coronary artery bypass grafting; CI: confidence interval; COPD:
chronic obstructive pulmonary disease; CPB: cardiopulmonary bypass;
EuroSCORE: European system for cardiac operative risk evaluation.
aCerebrovascular disease includes cerebral vascular accident, transient
ischaemic attack, reversible ischaemic neurological deficit,
subarachnoidal bleeding and epilepsy.
*Significance of type of surgery: P = 0.05 (reference category: CABG).
Table 5: Overview of variables associated with
postoperative infections in forward multivariable logistic
regression analysis
Type of
infection
Variables
Sternal
superficial
Morbid obesity, CRF, inotropes, total amount of
blood products.
Sternal deep Advanced age, higher BMI, smoking, diabetes
mellitus, cerebrovascular diseasea, Aspirin
preoperativelyb, CABG + valve replacement or
isolated valve replacement surgery, total amount
of blood transfusions.
Donor site Smoking, morbid obesity, CPB time, total amount of
blood products.
Sepsis Smoking, diabetes mellitus, renal dysfunction, aspirin
preoperativelyb, EuroSCORE, IABP, surgery other
than isolated CABG, total amount of blood
transfusions.
Urinary tract Female gender, advanced age, IABP, CPB time,
antifibrinolytics, surgery other than CABG and/or
valve surgery, total amount of blood products.
Pulmonary
tract
Female gender, advanced age, smoking, COPD,
digitalis preoperatively, β-blockers preoperativelyb,
cerebrovascular disease, IABP, reoperation,
prolonged CPB time, inotropes, total amount of
blood products.
BMI: body mass index; CABG: coronary artery bypass grafting; COPD:
chronic obstructive pulmonary disease; CPB: cardiopulmonary bypass;
CRF: chronic renal failure; EuroSCORE: European system for cardiac
operative risk evaluation; IABP: intra-aortic balloon pump.
aCerebrovascular disease includes cerebral vascular accident, transient
ischaemic attack, reversible ischaemic neurological deficit,
subarachnoidal bleeding and epilepsy.
bVariable is negatively related to type of infection.
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is a meta-analysis conducted by Hill et al., which provides evi-
dence that allogeneic blood transfusion is related to a signiﬁcantly
increased risk of postoperative infections in surgical patients [20].
Contrastingly, some discrepancy remains in other studies, which
may be due to differences in study population [8, 9]. A commonly
used explanation for this effect is the fact that, during blood trans-
fusion, large amounts of foreign antigens are introduced to the re-
cipients’ circulation. This may result in immune down-regulation,
which has been referred to as transfusion-associated immunomo-
dulation (TRIM). It is still unknown which speciﬁc component(s)
are responsible for the TRIM effect. However, a study conducted
by Leal-Noval et al. shows that red blood cell transfusion mediates
a shift in the balance between type 1 and type 2 CD4 T-helper
cells [21]. This cell response, in combination with other cell res-
ponses, plays an important role in the immune reaction following
cardiac surgery. Additionally, Vamvakas et al. reports that red blood
cell transfusion might provoke a fall in lymphocyte count [22].
Leucocyte depletion by ﬁltering of transfusion products has
been nationally applied since 2002 to reduce human leucocyte
antigen alloimmunization and transmission of cytomegalovirus in
high-risk patients. The role of white blood cells in immuno-
modulatory transfusion effects is thought to be substantial and,
therefore, leucocyte-depletion technology was expected to be of
advantage to diminish infectious diseases. However, studies
report contradictive results about whether leucocyte-depleted
transfusions reduce the incidence of infectious complications or
not [23–25]. One may speculate that blood transfusion continues
to induce a greater risk of infections because other constituents
than leucocytes are responsible for the TRIM effect. Additionally,
transfusion of several units may overwhelm functions of the
immune system, which causes bacterial clearance to be impaired.
Therefore, our data underlined the importance of diminishing
the amount of blood transfusion administrations both during
surgery and postoperatively. While time progresses, more patients
are admitted for cardiac surgery with higher risk proﬁles com-
pared with before. Every patient and procedure has its unique
circumstances, which have to be taken into account before
administering blood transfusion. It must be considered to what
extent blood products will contribute to an improvement of patients’
physical condition on the long term. Thus, re-examination of poten-
tial risks and beneﬁts in every situation is a perquisite.
STUDY LIMITATIONS
For interpretation, it is a necessity to understand the possible
factors of inﬂuence that are inherent to the observational study
design, most importantly bias and confounding. Patients’ and
surgery data were retrieved based on standard protocols, and
hence assessment bias is not likely for these variables. Physician’s
interpretation and opinions may have played a role in the detec-
tion and diagnosis of infections. Given the time span of the data-
base and number of patients in the database, it is likely that
numerous physicians were involved and, therefore, the results
reﬂect an average over all kinds of assessment attitudes of physi-
cians. In our opinion, this limits the inﬂuence of assessment bias.
However, omittance of ventilation time data precluded analysis of
factors related to development of pneumonia, which might be a
contributing factor as has been recently described by Riera et al.
[10]. Other factors that may be associated with infections but
could not be investigated were surgical error, surgical complica-
tion and reopening for bleeding. As these are markers for
complications, it would be expected that these would be implicitly
captured by e.g. perfusion and aorta cross-clamping times, which
were adjusted for in the analysis. By using multivariate regression,
the risk of confounding is reduced; however, confounding by indi-
cation as well as confounding by unmeasured and/or unknown
factors is as often difﬁcult to exclude.
CONCLUSION
This study conﬁrmed that predetermined risk factors are asso-
ciated with a higher incidence of post-cardiac surgery infections
and mortality. In particular, allogeneic blood transfusion showed
to be an independent risk factor for postoperative infections, and
therefore needs to be administered with caution.
ACKNOWLEDGEMENTS
We thank A.P. Simons for textual processing of the manuscript.
Conﬂict of interest: none declared.
REFERENCES
[1] Nosrati M, Boroumand M, Tahmasebi S, Sotoudeh M, Sheikhfathollahi M,
Goodarzynejad H. Excess costs associated with common healthcare-
associated infections in an Iranian cardiac surgical unit. J Hosp Infect 2010;
76:304–7.
[2] Graf K, Ott E, Vonberg RP, Kuehn C, Haverich A, Chaberny IF. Economic
aspects of deep sternal wound infections. Eur J Cardiothorac Surg 2010;
37:893–6.
[3] Michalopoulos A, Geroulanos S, Rosmarakis ES, Falagas ME. Frequency,
characteristics, and predictors of microbiologically documented nosoco-
mial infections after cardiac surgery. Eur J Cardiothorac Surg 2006;29:
456–60.
[4] Miholic J, Hudec M, Domanig E, Hiertz H, Klepetko W, Lackner F et al. Risk
factors for severe bacterial infections after valve replacement and aorto-
coronary bypass operations: analysis of 246 cases by logistic regression.
Ann Thorac Surg 1985;40:224–8.
[5] Chelemer SB, Prato BS, Cox PM Jr, O’Connor GT, Morton JR. Association of
bacterial infection and red blood cell transfusion after coronary artery
bypass surgery. Ann Thorac Surg 2002;73:138–42.
[6] Loop FD, Lytle BW, Cosgrove DM, Mahfood S, McHenry MC, Goormastic
M et al. J. Maxwell Chamberlain memorial paper. Sternal wound compli-
cations after isolated coronary artery bypass grafting: early and late mor-
tality, morbidity, and cost of care. Ann Thorac Surg 1990;49:179–86;
discussion 186–7.
[7] Murphy PJ, Connery C, Hicks GL Jr, Blumberg N. Homologous blood
transfusion as a risk factor for postoperative infection after coronary artery
bypass graft operations. J Thorac Cardiovasc Surg 1992;104:1092–9.
[8] Ali ZA, Lim E, Motalleb-Zadeh R, Ali AA, Callaghan CJ, Gerrard C et al.
Allogenic blood transfusion does not predispose to infection after cardiac
surgery. Ann Thorac Surg 2004;78:1542–6.
[9] Hughes MG, Evans HL, Lightfoot L, Chong TW, Smith RL, Raymond DP
et al. Does prior transfusion worsen outcomes from infection in surgical
patients? Surg Infect (Larchmt) 2003;4:335–43.
[10] Riera M, Ibanez J, Herrero J, Ignacio Sáez De Ibarra J, Enríquez F, Campillo
C et al. Respiratory tract infections after cardiac surgery: impact on hospital
morbidity and mortality. J Cardiovasc Surg (Torino) 2010;51:907–14.
[11] Ferguson TB Jr, Hammill BG, Peterson ED, DeLong ER, Grover FL,
Committee STSND. A decade of change—risk proﬁles and outcomes for
isolated coronary artery bypass grafting procedures, 1990–1999: a report
from the STS National Database Committee and the Duke Clinical
Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg 2002;
73:480–9; discussion 480–90.
[12] Choong CK, Sergeant P, Nashef SA, Smith JA, Bridgewater B. The
EuroSCORE risk stratiﬁcation system in the current era: how accurate is it
O
R
IG
IN
A
L
A
R
TI
C
LE
N.P.A. Vranken et al. / Interactive CardioVascular and Thoracic Surgery 237
and what should be done if it is inaccurate? Eur J Cardiothorac Surg 2009;
35:59–61.
[13] Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC deﬁnitions
of nosocomial surgical site infections, 1992: a modiﬁcation of CDC deﬁni-
tions of surgical wound infections. Am J Infect Control 1992;20:271–4.
[14] Nagachinta T, Stephens M, Reitz B, Polk BF. Risk factors for surgical-wound
infection following cardiac surgery. J Infect Dis 1987;156:967–73.
[15] Lee YP, Feng MC, Wu LC, Chen SH, Chen YH, Chiu CC et al. Outcome and
risk factors associated with surgical site infections after cardiac surgery in a
Taiwan medical center. J Microbiol Immunol Infect 2010;43:378–85.
[16] Berg TC, Kjorstad KE, Akselsen PE, Seim BE, Løwer HL, Stenvik MN et al.
National surveillance of surgical site infections after coronary artery
bypass grafting in Norway: incidence and risk factors. Eur J Cardiothorac
Surg 2011;40:1291–7.
[17] Leal-Noval SR, Marquez-Vacaro JA, Garcia-Curiel A, Camacho-Laraña P,
Rincón-Ferrari MD, Ordoñez-Fernández A et al. Nosocomial pneumonia
in patients undergoing heart surgery. Crit Care Med 2000;28:935–40.
[18] Kollef MH, Sharpless L, Vlasnik J, Pasque C, Murphy D, Fraser VJ. The
impact of nosocomial infections on patient outcomes following cardiac
surgery. Chest 1997;112:666–75.
[19] Salis S, Mazzanti VV, Merli G, Salvi L, Tedesco CC, Veglia F et al. Cardio-
pulmonary bypass duration is an independent predictor of morbidity and
mortality after cardiac surgery. J Cardiothorac Vasc Anesth 2008;22:814–22.
[20] Hill GE, Frawley WH, Grifﬁth KE, Forestner JE, Minei JP. Allogeneic blood
transfusion increases the risk of postoperative bacterial infection: a
meta-analysis. J Trauma 2003;54:908–14.
[21] Leal-Noval SR, Munoz-Gomez M, Arellano V, Adsuar A, Jiménez-
Sánchez M, Corcia Y et al. Inﬂuence of red blood cell transfusion on
CD4+ T-helper cells immune response in patients undergoing cardiac
surgery. J Surg Res 2010;164:43–9.
[22] Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation
(TRIM): an update. Blood Rev 2007;21:327–48.
[23] Titlestad IL, Ebbesen LS, Ainsworth AP, Lillevang ST, Qvist N, Georgsen J.
Leukocyte-depletion of blood components does not signiﬁcantly reduce
the risk of infectious complications. Results of a double-blinded, rando-
mized study. Int J Colorectal Dis 2001;16:147–53.
[24] Sharma AD, Slaughter TF, Clements FM, Sreeram G, Newman MF,
Phillips-Bute B et al. Association of leukocyte-depleted blood transfusions
with infectious complications after cardiac surgery. Surg Infect (Larchmt)
2002;3:127–33.
[25] Bilgin YM, van de Watering LM, Eijsman L, Versteegh MI, van Oers MH,
Brand A. Is increased mortality associated with post-operative infections
after leukocytes containing red blood cell transfusions in cardiac surgery?
An extended analysis. Transfus Med 2007;17:304–11.
eComment re: The role of patient’s proﬁle and allogeneic blood transfusion in
development of post-cardiac surgery infections: a retrospective study
Authors: Leo A. Bockeria and Dmitry A. Popov
Bakoulev Scientiﬁc Center for Cardiovascular Surgery, Moscow, Russia
doi: 10.1093/icvts/ivu180
© The Author 2014. Published by Oxford University Press on behalf of the European
Association for Cardio-Thoracic Surgery. All rights reserved.
We have read the article by Vranken et al. [1] with great interest. Using their large
clinical experience (7888 adult patients mainly undergoing coronary artery bypass
grafting (CABG) and CABG + valvular surgery), the authors studied the incidence of
infectious complications after cardiac surgery and the importance of blood product
transfusion as one of risk factors for their development.
Postoperative infection remains a problem in modern cardiac surgery, regardless of
improvements in surgical technique and antibacterial prophylaxis. Its development
cannot be explained only by failures in aseptic and antiseptic protocols during inter-
ventions. Compromised splanchnic perfusion and tissue ischaemia commonly
observed during cardiopulmonary bypass (CPB) can lead to decrease of mucosal
barrier function, allowing translocation of intestinal ﬂora and endotoxaemia which
can promote the development of infectious complications [2]. Therefore it is not sur-
prising that infection after surgery with CPB is not a rare phenomenon – an infectious
complication rate of up to 12% is reported in the current study. It would have been
better if the authors had described the criteria for infection more precisely. For in-
stance, body temperature of 37.5°C and pulmonary acoustics are not accurate for
pneumonia; the use of CPIS score would be more speciﬁc. So, at least, the rate of
pneumonia might be overestimated. The simple integral marker of body ischaemia is
blood lactate level. High lactate levels early postoperatively are strongly associated
with complications and poor outcome. Taking into consideration the above men-
tioned pathogenetic features we suggest that it would be very important to assess
blood lactate levels in connection with infection.
Typical victims of nosocomial infection are intensive care unit (ICU) patients.
Patients staying in the ICU for more than a couple of days due to various non-infec-
tious postoperative complications have a dramatically increased risk of infection.
According to the EPIC II multicentre study (14 414 patients were enrolled in 1265
ICUs in 76 European countries), the "normal" incidence of infection in ICU can reach
50%! [3]. In this connection it would be interesting to investigate the importance of
ICU length of stay in addition to the studied risk factors. Transfusion of blood and its
products, despite their undoubted life-saving effects, can be harmful due to the
wide spectrum of possible side effects and complications, including immune system
disturbances and organ injury (particularly the lungs). Obviously, it may predispose
to infection. From reading the article, the time of transfusion is not clear: whether it
was intraoperatively/early postoperatively due to acute blood loss, or later for
anaemia in critically ill patients staying in the ICU. We suggest that these groups
should be studied separately due to their completely different underlying
conditions.
Nevertheless, the article is very important for clinical practice, because it is postu-
lating one more time two very important things: infectious complications after heart
surgery are not rare and blood products must be used very carefully.
Conﬂict of interest: none declared.
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